Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.53 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.53 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.53 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.53 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.48 |
| ▸ | HMGCR | P04035 | 1/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4972584 | 0.88 | PTPN7 (0.59) | LMNAPTPN7HMGCRSLC22A6EPHX2 | |
| SCHEMBL416253 | 0.87 | HMGCR (0.52) | LMNAEGLN1ALKBH5SUCNR1PTPN7 | |
| SCHEMBL4972624 | 0.86 | PTPN7 (0.68) | LMNAPTPN7HMGCRSLC22A6EPHX2 | |
| SCHEMBL8847424 | 0.86 | PTPN7 (0.56) | PTPN7HMGCRSLC22A6EPHX2TDP1 | |
| SCHEMBL3104209 | 0.86 | — | — | |
| SCHEMBL939718 | 0.86 | — | — | |
| SCHEMBL4241662 | 0.84 | HMGCR (0.50) | LMNAEGLN1ALKBH5SUCNR1PTPN7 | |
| SCHEMBL29574312 | 0.84 | PTPN7 (0.72) | LMNAPTPN7HMGCRSLC22A6EPHX2 | |
| SCHEMBL28386570 | 0.84 | PTPN7 (0.72) | LMNAPTPN7HMGCRSLC22A6EPHX2 | |
| SCHEMBL6780232 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3709426-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | MITSUBISHI CHEM CORP (JP) | 2025-02-26 | — | — | EP | disclosed |
| US-20240154170-A1 | NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND ENERGY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-05-09 | — | — | US | disclosed |
| US-11631895-B2 | Nonaqueous electrolyte solution and energy device using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-04-18 | — | — | US | disclosed |
| EP-3780226-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEM CORP (JP) | 2022-05-11 | — | — | EP | disclosed |
| EP-3780226-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | Mitsubishi Chemical Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20210020991-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-01-21 | — | — | US | disclosed |
| EP-3709426-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | Mitsubishi Chemical Corporation (JP) | 2020-09-16 | — | — | EP | disclosed |
| US-20200274199-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-08-27 | — | — | US | disclosed |
| EP-3686983-A1 | NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND ENERGY DEVICE | Mitsubishi Chemical Corporation (JP) | 2020-07-29 | — | — | EP | disclosed |
| US-20200220222-A1 | NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND ENERGY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-07-09 | — | — | US | disclosed |
| WO-2004079393-A2 | THREE-DIMENTIONAL DOSIMETER FOR PENETRATING RADIATION AND METHOD OF USE | HEURIS PHARMA LLC (US) | 2004-09-16 | — | — | WO | disclosed |
| EP-0807101-B1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | UPJOHN CO (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-0980016-A1 | ALIGNING AGENT FOR LIQUID CRYSTAL | Nissan Chemical Industries, Ltd. (JP) | 2000-02-16 | — | — | EP | disclosed |
| US-5936000-A | 2-aminoindans as selective dopamine D3 ligands | PHARMACIA & UPJOHN COMPANY (US) | 1999-08-10 | — | — | US | disclosed |
| EP-0807101-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 1997-11-19 | — | — | EP | disclosed |
| WO-1996023760-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 1996-08-08 | — | — | WO | disclosed |
| US-4097642-A | URETHANE-CONTAINING | CIBA-GEIGY CORPORATION (US) | 1978-06-27 | — | — | US | disclosed |
| US-4054592-A | Urethanes containing two perfluoroalkylthio groups | CIBA-GEIGY CORPORATION (US) | 1977-10-18 | — | — | US | disclosed |
| US-4001305-A | POLYURETHANES, OIL AND WATER REPELLANT, MOLD-RELEASE | CIBA-GEIGY CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-3935277-A | OIL AND WATER REPELLENT INTERMEDIATES | CIBA-GEIGY CORPORATION (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11631895-B2 | Nonaqueous electrolyte solution and energy device using same | SLC26A3, VDAC3, SLC25A13 | LMNA 3230/4885EGLN1 2524/4885ALKBH5 4132/4885 |
| US-20200274199-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | SLC26A3, VDAC3, SLC25A13 | LMNA 3230/4885EGLN1 2524/4885ALKBH5 4132/4885 |
| US-20210020991-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | SLC9B2, SLC9A1, SLC9A2 | LMNA 2528/4885EGLN1 1741/4885ALKBH5 3662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.